Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria

MLA

De Oliveira, Dmp, et al. Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1340014438&authtype=sso&custid=ns315887.

APA

De Oliveira, D., Keller, B., Hayes, A., Ong, C.-L., Harbison-Price, N., El-Deeb, I., Li, G., Keller, N., Bohlmann, L., Brouwer, S., Turner, A., Cork, A., Jones, T., Paterson, D., McEwan, A., Davies, M., McDevitt, C., von Itzstein, M., & Walker, M. (2022). Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria.

Chicago

De Oliveira, Dmp, B Keller, Aj Hayes, C-Ly Ong, N Harbison-Price, Im El-Deeb, G Li, et al. 2022. “Neurodegenerative Disease Treatment Drug PBT2 Breaks Intrinsic Polymyxin Resistance in Gram-Positive Bacteria.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1340014438&authtype=sso&custid=ns315887.